Cargando…

Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers

BACKGROUND: Extrahepatic biliary duct cancers (EBDC) are uncommon malignancies characterized by a poor prognosis with high rate of loco-regional recurrence. The purpose of the present study is to assess the feasibility and the potential impact of adjuvant radiotherapy (RT) in a series of patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonet Beltrán, Marta, Roth, Arnaud D, Mentha, Gilles, Allal, Abdelkarim S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141778/
https://www.ncbi.nlm.nih.gov/pubmed/21702920
http://dx.doi.org/10.1186/1471-2407-11-267
_version_ 1782208754436014080
author Bonet Beltrán, Marta
Roth, Arnaud D
Mentha, Gilles
Allal, Abdelkarim S
author_facet Bonet Beltrán, Marta
Roth, Arnaud D
Mentha, Gilles
Allal, Abdelkarim S
author_sort Bonet Beltrán, Marta
collection PubMed
description BACKGROUND: Extrahepatic biliary duct cancers (EBDC) are uncommon malignancies characterized by a poor prognosis with high rate of loco-regional recurrence. The purpose of the present study is to assess the feasibility and the potential impact of adjuvant radiotherapy (RT) in a series of patients treated in one institution. METHODS: Twenty three patients with non-metastatic bile duct cancer treated surgically with curative intent (4 gallbladder, 7 ampullary and 12 cholangiocarcinoma) received 3D conformal external beam RT to a median total dose of 50.4Gy. Concurrent chemotherapy based on 5-FU was delivered to 21 patients (91%). Surgical margins were negative in 11 patients (48%), narrow in 2 (9%), and microscopically involved in 8 (35%). Eleven patients (55%) had metastatic nodal involvement. The average follow-up time for all patients was 30 months (ranging from 3-98). RESULTS: Acute gastrointestinal grade 2 toxicity (RTOG scale) was recorded in 2 patients (9%). Nausea or vomiting grade 1 and 2 was observed in 8 (35%) and 2 patients (9%) respectively. Only one patient developed a major late radiation-induced toxicity. The main pattern of recurrence was both loco-regional and distant (liver, peritoneum and/or lung). No difference was observed in loco-regional control according to the tumor location. The 5-year actuarial loco-regional control rate was 48.3% (67% and 30% for patients operated on with negative and positive/narrow/unknown margins respectively, p = 0.04). The 5-year actuarial overall survival was of 35.9% for the entire group (61.4% in case of negative margins and 16.7% in case of positive/narrow/unknown margins, p = 0.07). CONCLUSIONS: Postoperative RT with 50-60 Gy is feasible with acceptable acute and late toxicities. The potential benefit observed in our series may support the use of adjuvant RT in patients with locally advanced disease. Prospective randomized trials are warranted to confirm definitively the role of RT in this tumor location.
format Online
Article
Text
id pubmed-3141778
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31417782011-07-23 Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers Bonet Beltrán, Marta Roth, Arnaud D Mentha, Gilles Allal, Abdelkarim S BMC Cancer Research Article BACKGROUND: Extrahepatic biliary duct cancers (EBDC) are uncommon malignancies characterized by a poor prognosis with high rate of loco-regional recurrence. The purpose of the present study is to assess the feasibility and the potential impact of adjuvant radiotherapy (RT) in a series of patients treated in one institution. METHODS: Twenty three patients with non-metastatic bile duct cancer treated surgically with curative intent (4 gallbladder, 7 ampullary and 12 cholangiocarcinoma) received 3D conformal external beam RT to a median total dose of 50.4Gy. Concurrent chemotherapy based on 5-FU was delivered to 21 patients (91%). Surgical margins were negative in 11 patients (48%), narrow in 2 (9%), and microscopically involved in 8 (35%). Eleven patients (55%) had metastatic nodal involvement. The average follow-up time for all patients was 30 months (ranging from 3-98). RESULTS: Acute gastrointestinal grade 2 toxicity (RTOG scale) was recorded in 2 patients (9%). Nausea or vomiting grade 1 and 2 was observed in 8 (35%) and 2 patients (9%) respectively. Only one patient developed a major late radiation-induced toxicity. The main pattern of recurrence was both loco-regional and distant (liver, peritoneum and/or lung). No difference was observed in loco-regional control according to the tumor location. The 5-year actuarial loco-regional control rate was 48.3% (67% and 30% for patients operated on with negative and positive/narrow/unknown margins respectively, p = 0.04). The 5-year actuarial overall survival was of 35.9% for the entire group (61.4% in case of negative margins and 16.7% in case of positive/narrow/unknown margins, p = 0.07). CONCLUSIONS: Postoperative RT with 50-60 Gy is feasible with acceptable acute and late toxicities. The potential benefit observed in our series may support the use of adjuvant RT in patients with locally advanced disease. Prospective randomized trials are warranted to confirm definitively the role of RT in this tumor location. BioMed Central 2011-06-24 /pmc/articles/PMC3141778/ /pubmed/21702920 http://dx.doi.org/10.1186/1471-2407-11-267 Text en Copyright ©2011 Beltrán et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bonet Beltrán, Marta
Roth, Arnaud D
Mentha, Gilles
Allal, Abdelkarim S
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
title Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
title_full Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
title_fullStr Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
title_full_unstemmed Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
title_short Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
title_sort adjuvant radio-chemotherapy for extrahepatic biliary tract cancers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141778/
https://www.ncbi.nlm.nih.gov/pubmed/21702920
http://dx.doi.org/10.1186/1471-2407-11-267
work_keys_str_mv AT bonetbeltranmarta adjuvantradiochemotherapyforextrahepaticbiliarytractcancers
AT rotharnaudd adjuvantradiochemotherapyforextrahepaticbiliarytractcancers
AT menthagilles adjuvantradiochemotherapyforextrahepaticbiliarytractcancers
AT allalabdelkarims adjuvantradiochemotherapyforextrahepaticbiliarytractcancers